In the original article, there was a mistake in [**Figure 6D**](#f6){ref-type="fig"} as published. The final submission for the SCD1 bands in [**Figure 6D**](#f6){ref-type="fig"} was inadvertently truncated too short. The corrected [**Figure 6D**](#f6){ref-type="fig"} appears below.

![Modulation of Akt activation level has a feedback effect on the SCD1 level. Western blot for phospho-Akt (Ser-473), Akt, phospho-GSK3b (Ser-9),GSK3β, β-catenin, and SCD1 in T98G and U87 cells treated with pcDNA3.1, pcDNA-SCD1, EGF or pcDNA-SCD1 plus EGF **(A, B)**, or T98G-R and U87-R treated with DMSO, A939572, MK2206, A939572 plus MK2206, LY294002 and A939572 plus LY294002 **(C, D)**. All western blots are representative of results from at least three independent experiments. And α-Tubulin was used as the internal control.](fphar-10-01358-g006){#f6}

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
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